This company listing is no longer active
B2A Stock Overview
Engages in the production and sale of organic and herbal products, natural cosmetics, and traditional food products in Italy. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 0/6 |
| Dividends | 0/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
Bioera S.p.A. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €0.024 |
| 52 Week High | €0.11 |
| 52 Week Low | €0.018 |
| Beta | 0 |
| 1 Month Change | 0% |
| 3 Month Change | 0% |
| 1 Year Change | -6.15% |
| 3 Year Change | -96.20% |
| 5 Year Change | -99.56% |
| Change since IPO | -99.86% |
Recent News & Updates
Recent updates
Shareholder Returns
| B2A | DE Personal Products | DE Market | |
|---|---|---|---|
| 7D | 0% | -2.1% | 0.8% |
| 1Y | -6.2% | -9.8% | 14.6% |
Return vs Industry: B2A exceeded the German Personal Products industry which returned -7.3% over the past year.
Return vs Market: B2A underperformed the German Market which returned 14.7% over the past year.
Price Volatility
| B2A volatility | |
|---|---|
| B2A Average Weekly Movement | n/a |
| Personal Products Industry Average Movement | 5.2% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in DE Market | 12.9% |
| 10% least volatile stocks in DE Market | 3.1% |
Stable Share Price: B2A's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: Insufficient data to determine B2A's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2004 | 4 | Giorgio Campeggio | www.bioera.it |
Bioera S.p.A. engages in the production and sale of organic and herbal products, natural cosmetics, and traditional food products in Italy. The company markets its products under the KI, Crudigno, and Fonte della Vita brand names; and distributes its products through outsourcers. The company was founded in 2004 and is headquartered in Milan, Italy.
Bioera S.p.A. Fundamentals Summary
| B2A fundamental statistics | |
|---|---|
| Market cap | €810.50k |
| Earnings (TTM) | -€6.20m |
| Revenue (TTM) | €1.15m |
0.0x
P/S Ratio0.0x
P/E RatioIs B2A overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| B2A income statement (TTM) | |
|---|---|
| Revenue | €1.15m |
| Cost of Revenue | €1.17m |
| Gross Profit | -€21.00k |
| Other Expenses | €6.18m |
| Earnings | -€6.20m |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0 |
| Gross Margin | 0.00% |
| Net Profit Margin | 0.00% |
| Debt/Equity Ratio | 0.0% |
How did B2A perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/03/03 05:23 |
| End of Day Share Price | 2024/12/04 00:00 |
| Earnings | 2023/06/30 |
| Annual Earnings | 2022/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Bioera S.p.A. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.